Dr. Keralla Gebraeil Hanna, MD

Dr. Hanna practices at ArchCare at Mother Cabrini Hospital at Terence Cardinal Cooke in New York, New York, part of Archdiocese of New York.

Dr. Hanna's NPI, 1104400860, was assigned on May 10, 2021. Dr. Hanna graduated from Damascus University Faculty of Medicine in 1986. Dr. Hanna holds New York license 199933.

Dr. Hanna's primary practice is ArchCare at Mother Cabrini Hospital at Terence Cardinal Cooke, at 1249 Fifth Avenue, New York, NY 10029.

Dr. Hanna's primary practice is ArchCare at Mother Cabrini Hospital at Terence Cardinal Cooke in New York, New York, part of Archdiocese of New York. The medical group on file is Essen Medical Associates. Dmand AI also links Dr. Hanna to 3 more group practices and clinics, 2 medical groups, 1 home health agency, 1 hospital outpatient department and 1 skilled nursing facility, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hanna practices, 7 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Hanna's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Hanna is licensed in New York.

CMS data shows 3,598 Medicare services from Dr. Hanna across 8 procedure codes in 2024, for 387 Medicare patients. Medicare paid $266,529 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 387 Medicare patients who saw Dr. Hanna in 2024. The largest group is 65 to 74, with 139 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 87% are also on Medicaid. Their average risk score is 3.65, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hanna's median patient age at 73, with 42% women.

In 2024, Dr. Hanna wrote 4,659 Medicare Part D claims for 274 patients. 80% of them were for generic drugs. CMS names the drug for 4,020 of them, across 99 drugs with 11 or more claims each, at $421,920 in total drug cost. In 2023, CMS named 3,293 claims across 91 drugs.

Dr. Hanna accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 113 general payments to Dr. Hanna from 9 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 100% of the total. Neurocrine BioSciences, Inc. paid the most, $883.

Dr. Hanna graduated from Damascus University Faculty of Medicine in 1986.